Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGateley Holdings Regulatory News (GTLY)

Share Price Information for Gateley Holdings (GTLY)

Share Price is delayed by 15 minutes
Get Live Data
52.00    -0.40 (-0.76%)
Bid:
51.00
Ask:
53.00
Spread: 2.00 (3.922%)
Market Cap: £70.27m
GTLY Live PriceLast checked at - London Stock Exchange

Intraday Gateley Holdings Share Chart

Proposed Placing

20 Oct 2021 16:46

RNS Number : 7191P
Gateley (Holdings) PLC
20 October 2021
 

 

 20 October 2021

THIS ANNOUNCEMENT, INCLUDING THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY NEW ORDINARY SHARES OF GATELEY (HOLDINGS) PLC IN THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by The Market Abuse (Amendment) (UK MAR) Regulations 2019. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Gateley (Holdings) Plc

("Gateley", the "Company" or the "Group")

Proposed Placing

Gateley (AIM: GTLY), the legal and professional services group, today announces that it has been notified by certain Directors and employees (together the "Selling Shareholders") of their intention to sell approximately 5,000,000 existing ordinary shares of 10 pence each in the capital of the Company (or such other number as the Selling Shareholders and the Bookrunner agree) at a price of 220 pence per Placing Share. The Placing Shares represent approximately 4.2 per cent. of the issued share capital of the Company.

Liberum Capital Limited ("Liberum") is acting as sole bookrunner in relation to the Placing.

The Placing will be effected by way of an accelerated bookbuild to institutional investors which will be launched immediately following this announcement ("Bookbuild"). The final number of Placing Shares to be placed and the price at which the Placing Shares are to be placed will be agreed by Liberum and the Selling Shareholders at the close of the bookbuild process. The timing of the closing of the Bookbuild and the distribution of allocations are at the discretion of Liberum and a further announcement confirming these details will be made in due course. Liberum reserves the right to close the Bookbuild without further notice. There can be no certainty that the Placing will complete.

The Selling Shareholders have entered into a block trade agreement with Liberum pursuant to which Liberum has agreed to act as the Selling Shareholders' agent in connection with the Placing.

Enquiries:

Gateley (Holdings) Plc

Neil Smith, Finance Director

Tel: +44 (0) 121 234 0196

Nick Smith, Acquisitions Director and Head of Investor Relations

Tel: +44 (0) 20 7653 1665

Cara Zachariou, Head of Corporate Communications

Tel: +44 (0) 121 234 0074 /

Mob: +44 (0) 7703 684 946

Liberum - Nominated adviser and Broker

Richard Lindley / Ben Cryer / Cara Murphy

Tel: +44 (0) 20 3100 2000

Belvedere Communications Limited - Financial PR

Cat Valentine (cvalentine@belvederepr.com)

Mob: +44 (0) 7715 769 078

Keeley Clarke (kclarke@belvederepr.com)

Mob: +44 (0) 7967 816 525

Llew Angus (langus@belvederepr.com)

Mob: +44 (0) 7407 023 147

gateleypr@belvederepr.com

 

Market Abuse Regulation

Market soundings, as defined in MAR, were taken in respect of the Placing, with the result that certain persons became aware of inside information, as permitted by MAR. That inside information is set out in this announcement and has been disclosed as soon as possible in accordance with paragraph 7 of article 17 of MAR. Therefore, those persons that received inside information in a market sounding are no longer in possession of inside information relating to the Company and its securities.

 

Important Notice:

MEMBERS OF THE GENERAL PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE PLACING. THIS ANNOUNCEMENT AND ANY OFFER OF SECURITIES TO WHICH IT RELATES ARE ONLY ADDRESSED TO AND DIRECTED AT (1) IN ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA, PERSONS WHO ARE QUALIFIED INVESTORS WITHIN THE MEANING OF ARTICLE 2(E) OF THE PROSPECTUS REGULATION 2017/1129 ("PROSPECTUS REGULATION"); AND (2) IN THE UNITED KINGDOM, PERSONS WHO ARE QUALIFIED INVESTORS AS DEFINED WITHIN THE PROSPECTUS REGULATION AS IT FORMS PART OF RETAINED UK LAW BY VIRTUE OF THE EUROPEAN UNON (WITHDRAWAL) ACT 2018 AND (I) HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS WHO FALL WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005 (AS AMENDED) (THE "ORDER"); OR (II) FALL WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER OR (III) ARE PERSONS TO WHOM AN OFFER OF THE PLACING SHARES MAY OTHERWISE LAWFULLY BE MADE (ALL SUCH PERSONS REFERRED TO IN (1) AND, (2) TOGETHER BEING REFERRED TO AS "RELEVANT PERSONS"). THE INFORMATION REGARDING THE PLACING SET OUT IN THIS ANNOUNCEMENT MUST NOT BE ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED IN ONLY WITH RELEVANT PERSONS.

This announcement and the information contained herein is for information purposes only and does not constitute or form part of any offer or an invitation to acquire or dispose of securities in the United States, Canada, Australia, South Africa or Japan or in any jurisdiction in which such an offer or invitation is unlawful.

The Placing Shares have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "Securities Act"), or under the securities laws of any State or other jurisdiction of the United States, and, absent registration, may not be offered or sold in the United States (as defined in Regulation S under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and the securities laws of any relevant State or other jurisdiction of the United States. There will be no public offering of the Placing Shares in the United States or elsewhere.

The Placing Shares have not been approved or disapproved by the US Securities and Exchange Commission, any state securities commission or other regulatory authority in the United States, nor have any of the foregoing authorities passed upon or endorsed the merits of the Placing or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States.

No prospectus or offering document has been or will be prepared in connection with the Placing. Any investment decision to buy securities in the Placing must be made solely on the basis of publicly available information. Such information is not the responsibility of and has not been independently verified by the Selling Shareholders, Liberum or any of their respective affiliates.

Neither this announcement nor any copy of it may be taken, transmitted or distributed, directly or indirectly, in or into or from the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada, the Republic of South Africa or Japan. Any failure to comply with this restriction may constitute a violation of US, Australian, Canadian, South African or Japanese securities laws.

The distribution of this announcement and the offering or sale of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken by the Selling Shareholders, Liberum or any of their respective affiliates that would, or which is intended to, permit a public offer of the Placing Shares in any jurisdiction, or possession or distribution of this announcement or any other offering or publicity material relating to the Placing Shares, in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Selling Shareholders and Liberum to inform themselves about and to observe any applicable restrictions.

No reliance may be placed, for any purposes whatsoever, on the information contained in this announcement or on its completeness and this announcement should not be considered a recommendation by the Company, the Selling Shareholders, Liberum or any of their respective affiliates in relation to any purchase of or subscription for securities of the Company. No representation or warranty, express or implied, is given by or on behalf of the Company, the Selling Shareholders, Liberum or any of their respective directors, partners, officers, employees, advisers or any other persons as to the accuracy, fairness or sufficiency of the information or opinions contained in this announcement and none of the information contained in this announcement has been independently verified. Save in the case of fraud, no liability is accepted for any errors, omissions or inaccuracies in such information or opinions.

Liberum, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting only for the Selling Shareholders in connection with the Placing and will not be responsible to anyone other than the Selling Shareholders for providing the protections offered to the clients of Liberum, nor for providing advice in relation to the Placing or any matters referred to in this announcement, and apart from the responsibilities and liabilities (if any) imposed on Liberum by FSMA, any liability therefore is expressly disclaimed. Any other person in receipt of this announcement should seek their own independent legal, investment and tax advice as they see fit.

References to time in this announcement are to London time, unless otherwise stated. All times and dates in this announcement may be subject to amendment.

Certain statements in this announcement are forward-looking statements. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial consequences of the plans and events described herein. No one undertakes any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Readers should not place any undue reliance on forward-looking statements which speak only as of the date of this announcement. Statements contained in this announcement regarding past trends or events should not be taken as representation that such trends or events will continue in the future.

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEBLFLFBLXFBK
Date   Source Headline
4th Jun 20267:00 amRNSFY 2026 Trading Update
1st May 20267:00 amRNSChief Financial Officer Succession Update
8th Apr 20267:00 amRNSTR-1: Notification of Major Holdings
11th Mar 20267:00 amRNS-RAgreement to deploy the Jylo AI platform
11th Mar 20267:00 amRNS-RAgreement to deploy the Jylo AI platform
4th Feb 202612:00 pmRNSPDMR Dealings and TVR
30th Jan 20267:00 amRNSShare Purchase
22nd Jan 20263:10 pmRNSShare Purchase by Non-Executive Director
19th Jan 20264:06 pmRNSTR-1: Notification of Major Holdings
12th Jan 20262:04 pmRNSDirector / PDMR Shareholding
22nd Dec 20253:37 pmRNSIssue of Equity relating to GWW and TVR
22nd Dec 20253:37 pmRNSIssue of Equity relating to GWW and TVR
9th Dec 20257:00 amRNSHalf year results
20th Nov 202510:08 amRNSNotice of results
30th Oct 202511:44 amRNSEBT Share Purchase / PDMR Dealings
9th Oct 20256:19 pmRNSNotification of Major Holdings
7th Oct 20254:16 pmRNSShare Purchase by Non-Executive Director
24th Sep 20251:43 pmRNSResult of 2025 Annual General Meeting
18th Sep 20253:40 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSCFO Succession
9th Sep 202510:52 amRNSIssue of Equity relating to Gateley RJA and TVR
2nd Sep 20257:00 amRNSPDMR Dealings and TVR
1st Sep 20257:00 amRNSAcquisition of Groom Wilkes & Wright LLP
28th Aug 20257:00 amRNSAnnual Report and Notice of AGM
6th Aug 20257:00 amRNS-RResponsible Business Report
31st Jul 20257:00 amRNSTotal Voting Rights
28th Jul 20257:00 amRNSDirectorate Change
15th Jul 20259:48 amRNSCORRECTED Full Year Results
15th Jul 20257:00 amRNSFull Year Results
3rd Jun 20257:00 amRNSFY 2025 Trading Update
22nd Apr 20257:00 amRNSDirectorate Change
14th Apr 20259:20 amRNSNew Revolving Credit Facility agreed for £80m
15th Jan 20257:00 amRNSHalf Year Results
27th Nov 20247:00 amRNSH1 25 Trading update and notice of results
1st Nov 20241:35 pmRNSDirector/PDMR Shareholding
30th Oct 20249:24 amRNSNotification of Major Holdings
8th Oct 20247:00 amRNSEBT Share Purchase / PDMR Dealings
26th Sep 20248:26 amRNS2024 Final Dividend Timetable
23rd Sep 20244:08 pmRNSResult of AGM
20th Sep 20243:56 pmRNSGrant of SAYE Options and PDMR Dealings
9th Sep 202412:28 pmRNSShare Purchase by Non-Executive Director
3rd Sep 202411:02 amRNSShare Purchase by Non-Executive Director
30th Aug 20247:00 amRNSAnnual Report and Notice of AGM
22nd Aug 20247:00 amRNSNon-Executive Director and Chair Designate Appt
9th Aug 20247:00 amRNSShare Purchase by Non-Executive Director
1st Aug 20247:00 amRNSIssue of Equity relating to Gateley RJA and TVR
25th Jul 20241:45 pmRNSGrant of Share Awards and PDMR Dealings
16th Jul 20247:00 amRNSAudited Results 2024
1st Jul 202411:27 amRNSTR-1
1st Jul 20247:00 amRNSNominated Adviser and Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.